Skip to content

A clinical trial to study the neurocognitive effects of tdcs in patients with schizophrenia

Neurocognitive effects of Anodal left Prefrontal Transcranial Direct Current Stimulation in patients with Schizophrenia, A Randomized double blinded sham controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/04/013039
Enrollment
66
Registered
2018-04-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- patients with schizophrenia

Interventions

Intervention1: transcranial direct current stimulation: Anode will be placed in F3 position of the international 10/20 mapping system and cathode in FP2 position .Each participant of active group wil

Sponsors

Kasturba medical college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with schizophrenia (F20) according to ICD-10 Diagnostic Criteria for Research (DCR) 2. Age between: 18 and 60 of either sex 3. Patients who are on same psychotropic medication for at least 3 months 4. No ECTs in the last six months. 5. Patients who consent to participate (Informed consent) 6. 6 years of formal education

Exclusion criteria

Exclusion criteria: 1. Comorbid major psychiatric disorders, substance dependence excluding tobacco use 2. Chronic major medical or neurological disorders 3. Subjects with skeletal deformities of scalp 4. Metallic implants 5. Change in medication in the last 3 months. 6. Eligibility criteria for the control group will be the same

Design outcomes

Primary

MeasureTime frame
MCCB (MATRICS Consensus Cognitive Battery) ,the mean changes of the changes across the domains of the battery will be assessedTimepoint: a baseline assessment of MCCB will be done 1 day prior to the recruitment and then assessments will be done again one hour after 10th session of tdcs and after one month after the tdcs procedure

Secondary

MeasureTime frame
PANSS: Positive and Negative Syndrome Scale for Schizophrenia CGI: Clinical Global Impression SCoRS: Schizophrenia Cognition Rating Scale TDCS adverse effect questionnaire Timepoint: before the interventions is started and then after tenth session of tdcs and after 1 month

Countries

India

Contacts

Public ContactDr P PRAVEEN REDDY

Department of psychiatry Kasturba Medical College Manipal Udupi Karnataka

samirpsyche@yahoo.co.in8971026304

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026